Osteoblasts are the bone forming cells, capable of secreting an extracellular matrix with mineralization potential. The exact mechanism by which osteoblasts differentiate and form a mineralized extracellular matrix is presently not fully understood. To increase our knowledge about this process, we conducted proteomics analysis in human immortalized preosteoblasts (SV-HFO) able to differentiate and mineralize. We identified 381 proteins expressed during the time course of osteoblast differentiation. Gene ontology analysis revealed an overrepresentation of protein categories established as important players for osteoblast differentiation, bone formation, and mineralization such as pyrophosphatases. Proteins involved in antigen presentation, energy metabolism and cytoskeleton rearrangement constitute other overrepresented processes, whose function, albeit interesting, is not fully understood in the context of osteoblast differentiation and bone formation. Correlation analysis, based on quantitative data, revealed a biphasic osteoblast differentiation, encompassing a premineralization and a mineralization period. Identified differentially expressed proteins between mineralized and nonmineralized cells include cytoskeleton (e.g., CCT2, PLEC1, and FLNA) and extracellular matrix constituents (FN1, ANXA2, and LGALS1) among others. FT-ICR-MS data obtained for FN1, ANXA2, and LMNA shows a specific regulation of these proteins during the different phases of osteoblast differentiation. Taken together, this study increases our understanding of the proteomics changes that accompany osteoblast differentiation and may permit the discovery of novel modulators of bone formation.
Introduction
Bone is a highly specialized form of connective tissue. It is very dynamic, being continuously resorbed by osteoclasts and rebuild by osteoblasts. Osteoblasts are the bone-forming cells. They synthesize an extracellular matrix (ECM) and participate in the mineralization of this matrix. While the majority of osteoblasts enter apoptosis, the remainder enters the last stage of osteoblast differentiation becoming osteocytes. The process of osteoblast differentiation from the mesenchymal stem cell (MSC) lineage is tightly regulated and encompasses several steps. Expression of the osteoblasts-specific transcription factors Runx2 and Osterix is essential to drive MSCs toward the osteoblastic lineage. [1] [2] [3] After lineage commitment, several differentiation steps take place until the formation of mature osteoblasts. These cells are characterized by the expression of the matrix proteins collagen type I, osteocalcin, osteopontin, bone sialoprotein, and alkaline phosphatase (ALP), an enzyme which is believed to be involved in bone matrix mineralization. 4 In vitro, human osteoblast differentiation can be triggered by glucocorticoids, [5] [6] [7] in a process not completely understood. An important step toward understanding osteoblast differentiation is to characterize the osteoblast proteome during differentiation. Over the last years, proteomics technology has made tremendous progress, 8, 9 and nowadays, mass spectrometry (MS)-based proteomics tools can be applied to generate not only qualitative, but also quantitative information, to gain a more holistic view of biological systems. 8 Several proteomic studies have been conducted to unravel the mechanisms underlying osteogenesis. [10] [11] [12] [13] [14] Yet only a portion of the osteoblast proteome has been unveiled and additional, quantitative proteomic analyses are needed to reach the goal of capturing the full osteoblast proteome.
In this study, we aimed to extend the knowledge about human osteogenesis by investigating the protein expression during the time-course of glucocorticoid-induced osteoblast differentiation and mineralization (differentiating osteoblasts). For this purpose, we used the well-characterized preosteoblast cell line SV-HFO 15 that develops into mature osteoblasts in a 3-week time period in the presence of glucocorticoids. 5 Two mass spectrometry platforms were used for purposes of remove Rapigest hydrolytic byproduct (final TFA concentration 0.5%, pH < 2). Finally, samples were aliquoted and stored at -80°C until use for LC-MS/MS and MALDI-FT-ICR-MS.
LC-MS/MS.
One microliter of protein sample was injected onto a nanoLC system (Dionex, Amsterdam, The Netherlands) and trapped for 7.5 min on a C18 PepMap 100 column (5 mm ×300 µm i.d., Dionex, Sunnyvale, CA). Fractionation was performed using a C18 PepMap 100 column (150 mm ×75 µm, 3 µm, 100 Å, Dionex, Sunnyvale, CA) using a 80 min gradient running from 0-50% of buffer A (80% acetonitrile (ACN), 20% H 2 O, 0.1% TFA) in buffer B (100% H 2 O, 0.1% TFA), followed by a 23.5 min gradient to 100% B at 250 nL/min (Dionex). A UV detector (214 nm) was used to monitor the separation. The nanoLC was coupled to a LTQ-Orbitrap (Thermo Fisher Scientific, Bremen, Germany). Mass spectrometry data was acquired in both data-independent and dependent mode, the latter to include those peptide masses found to be differentially expressed by MALDI-FT-ICR-MS measurements (see below) for specific sequencing. This preselection of data results in an increased chance to identify the peptides of interest than just by default data independent measurements. The mass tolerance of the selected inclusion list was 10 ppm.
Fragmentation spectra were searched against the Human International Protein Index (IPI) database v3.18 (June 13, 2006) with SEQUEST using the Bioworks software (Version 3.3, Thermo Electron, San Jose, CA). The mass accuracy for the database was set to 5 ppm for the precursor ions and 1 Da for the fragment ions. Only peptides with a probability less than 0.001 and meeting the SEQUEST HUPO PPP high confidence parameters 18, 19 were considered for further analysis.
Peptides masses within a mass window of 7 ppm to LC-MS/ MS and 2 ppm to the FT-ICR-MS (see section below) measurements were considered as identified. To verify isoform specificity and eliminate redundant protein identifications, the peptides were searched against the same IPI Human database using Standalone Blast (Basic Local Alignment Search Tool) software version 2.2.17 with the PAM30 scoring matrix for short amino acid sequences. Sequence coverage determination was performed using the Protein Coverage Summarizer v1.2.3064 tool, freely available in the PNNL/OMICS.PNNL.GOV Web site (http://omics.pnl.gov/software/ProteinCoverageSummarizer. php).
Bioinformatic Gene Ontology Analysis. Proteins identified in the normal scan mode by LC-MS/MS were analyzed using Ingenuity Pathway Analysis (version 7.60) and DAVID BioinformaticsResourcesv6.7(http://david.abcc.ncifcrf.gov/home.jsp) 20, 21 to obtain a comprehensive description of the overrepresented biological processes and functional related groups of proteins within our data set. For DAVID analysis, only Bonferroni significant (p-value < 0.001) overrepresented terms, containing more than 9 proteins, were considered. As background, the default Homo sapiens genome was used.
MALDI-FT-ICR-MS.
Half microliter of protein sample was mixed with a 2,5-dihydroxy benzoic acid (DHB, Bruker Daltonics, Bremen, Germany) matrix solution (10 mg/mL in 0.1% TFA/water) in a 1:1 (v/v) ratio, spotted onto a 600/384 AnchorChip target plate (Bruker Daltonics) in duplicate, and allowed to dry at room temperature. MALDI-FTICR MS measurements were performed in a Bruker Apex-Q equipped with a 9.4 T magnet (Bruker Daltonics). For each measurement, scans of 10 shots at 75% laser power were accumulated. Mass spectra were acquired in the mass range of 800-4000 Da and processed with a Gaussian filter and 2 zero fillings. To ensure good mass accuracy, an external calibration was performed using a Peptide Calibration Standard II (Bruker Daltonics), a mixture that contains Bradykin 1-7, Angiotensin II, Angiotensin I, Substance P, Bombesin, Renin Substrate, ACTH clip 1-17, ACTH clip 18-39, and Somatostatin 28. The 18 samples were measured randomly in triplicate and a total of 54 individual spectra were acquired.
Internal Calibration of FT-ICR-MS Data. Raw files obtained from the FT-ICR-MS were used as input for homemade software described elsewhere. [22] [23] [24] On the basis of these peptides, an average accuracy of less than 1 ppm was obtained. The final matrix contained all masses detected and their respective intensities, in at least 3 independent measurements and with a signal-tonoise (S/N) > 4 to avoid noise peaks.
Normalization of FT-ICR-MS Data. Normalization of the measured intensities was achieved multiplying them by a normalization factor. This factor was determined by the ratio of average intensity of all samples to average intensity of the sample to be normalized. After normalization, we inspected the reproducibility for both technical and biological replicates by calculating the coefficient of variance of the 63 peptide masses detected in all samples. For technical replicates, the average CV was 11% (range 7-15%), and, for biological replicates, the CV was 26% (range 19-36%).
Selection of Differentially Expressed Peptides. Comparison of normalized peptide intensities, including zero values, was performed using a Wilcoxon test. 24 In a first set of analysis, peptide intensities at a specific culture time point (day 5, day 10, or day 19) were compared between nondifferentiating and differentiating samples. In a second set of analysis, peptide intensities were compared as a function of time during culture for both nondifferentiating and differentiating conditions. Peptide masses with a p-value < 0.001 and a p-value < 0.01 showing an absolute difference (present and absent) between the compared conditions were identified as being differently expressed.
Data Visualization. The geometrical mean of the normalized intensities of all samples was calculated. Values of intensity equal to 0 were regarded as Not a Number (NaN). The level of expression of each peptide mass in every sample was determined relative to this geometric mean and logarithmically transformed (on a base 2 scale). Deviation from the geometrical mean was considered as differential expression, despite possible unaccountable bias introduced by the MALDI ionization process and the analyte interaction with the matrix used. To minimize the latter possibility, we have measured all samples in triplicate, observing acceptable CVs (7-15%) in contrast to other equipments, like the MALDI-TOF, where CVs can be as high as 30%. Similarity between samples, plotted by Pearson's correlation, was done using Omniviz (OmniViz, Maynard, MA, version 5.0).
Immunodetection. Cell culture and protein isolation for Western blotting experiments were identical to those described above. Equal amounts of protein per sample were loaded and separated by SDS-PAGE (10% Ready Gel Precast Gels, Bio-Rad, Hercules, CA) and transferred onto a nitrocellulose membrane (Hybond-ECL, Amersham Biosciences, Buckinghamshire, U.K.). After blocking nonspecific signal with 4% fat free milk in Trisbuffered saline (TBS), the membrane was incubated with specific antibodies against fibronectin (mouse monoclonal to FN1; 1:5000, Ab-11, Clone FBN11, NeoMarkers, Cat. MS-1351), annexin A2 (rabbit polyclonal to ANXA2; 1 µg/mL, Abcam, Cat. Ab41803), and GAPDH (loading control; mouse monoclonal; 1:20 000, Millipore, Cat. MAB374). Membranes were probed with secondary antibodies, goat anti-mouse or goat anti-rabbit IgG, conjugated with Alexa Fluor 680 (1:5000, Invitrogen, Cat. A21057) or with IRDye 800CW (1:5000, LI-COR, Cat. 926-32211), respectively. Immunoreactive bands were visualized using the LI-COR Infrared Imaging System according to the manufacturer's instructions (Odyssey Lincoln, NE).
FN1 expression was visualized by immunocytochemistry. Nondifferentiating and differentiating cells were cultured in similar conditions used for the MS analysis. After fixation in 10% formalin and blocking in PBS/2% BSA, cells were incubated with mouse monoclonal FN1 antibody (1:100, Ab-11, Clone FBN11, NeoMarkers, Cat. MS-1351). Next, slides were incubated with secondary antibody, goat anti-mouse IgG conjugated with Alexa Fluor 680 (1:300, Invitrogen, Cat. A21057). Slides were washed 3 times in PBS/0.2% BSA, one time in PBS, one time in 70% ethanol, and finally in 100% ethanol. After washing, they were mounted in VectaShield containing DAPI (Vector Laboratories, Burlingame, CA). As negative control, cells were not incubated with primary antibody.
Results

ALP Activity and Mineralization of Human Preosteoblasts.
In this study, human preosteoblasts (SV-HFO) were used, which can be stimulated to differentiate into mature osteoblasts that produce a collagenous ECM that subsequently accumulates mineral. Measuring parameters such as ALP activity and calcium deposition over time can monitor this process. As shown in Figure 1A , differentiating osteoblasts exhibited an increase in ALP activity with a peak around day 10. The ALP increase was followed by a rapid deposition of calcium ( Figure  1B ). This in vitro bone formation model is an excellent model to study protein expression within the different stages of osteoblast differentiation.
Qualitative LC-MS/MS Proteome Analysis: Proteins Identified in Differentiating Human Osteoblast Cultures. To identify as many as possible proteins, we combined chromatographic techniques upstream to detailed MS measurements (nano-LC-MS/MS). We have used the capabilities of this technique to get qualitative insights into the proteins expressed by differentiating osteoblasts combining data from days 5, 10, and 19. This resulted in the successful identification of 381 proteins (Supplementary Table 1 ). To categorize the identified osteoblast proteins, we performed gene ontology (GO) annotation overrepresentation analyses. The proteins were categorized for their annotation related to Biological Process (BP), Molecular Function (MF), and Cellular Compartment (CC). Figure  2A depicts the significant top GO term categorization by overrepresentation. Several overrepresented terms were related to cytoskeleton such as structural constituent of the cytoskeleton (GO:0005200), actin cytoskeleton (GO:00015629), and actin filament-based process (GO:0030029). Pyrophosphatase activity (GO:0016462) proteins were overrepresented, as well as proteins involved in other distinct processes like energy metabolism (GO:0006096) or antigen processing and presentation (GO: 0042612; GO:0002474). In addition, the proteins were also categorized in protein families ( Figure 2B ). Enzymes were the second biggest group of proteins (85 proteins) followed by transporters (18) . Phosphatases and ion channels (5 proteins each) were also detected and represent an interesting group of proteins for the process under study, where phosphate and calcium ions represent the foundations for ECM mineralization.
We further inspected for proteins identified and GO annotations that are established players in osteoblast differentiation (Table 1) . We have identified 5 proteins linked to skeletal system development, several ECM components including collagens and collagen binding proteins, and proteins that bind to integrins, which are important for ECM-cell signal transduction and osteoblast function (reviewed by Damsky et al., 1999) . Other osteoblast-relevant categories included proteins possessing pyrophosphatase activity and calcium ion binding proteins with 41 and 29 proteins, respectively.
Quantitative MALDI-FT-ICR-MS Proteome Analysis: Differentially Expressed Proteins in Mineralization Period.
Following the qualitative analysis, we used MALDI-FT-ICR-MS to gather quantitative protein expression profiles. A total of 54 individual spectra were obtained corresponding to the day 5, 10, and 19 of differentiating and nondifferentiating conditions, analyzed in 3 biological and 3 technical replicates. Data was used as input for homemade software 24 in order to generate a data file containing all information regarding to peptide masses detected and their respective intensities. For each spectrum, we obtained 1688-2204 monoisotopic masses. The exception was one spectrum, a technical replicate of a sample from day 10 nondifferentiating condition, that showed only 814 masses and which was excluded from further analysis. Upon performing internal calibration, we obtained an average accuracy below 1 ppm in agreement with previous reports using similar equipment. 26, 27 We compared all samples according to the criteria mentioned in the Material and Methods (Selection of Differentially Expressed Peptides) and identified 422 peptide masses as significantly differentially expressed. Correlation analysis based on measured intensities of these 422 peptide masses is shown in Figure 3 . It is interesting that this unbiased approach delivered a correlation plot with a divergence of the differentiating and nondifferentiating conditions. Within the differentiating condition, there was also a clear discrepancy between the premineralization and mineralization periods, with a very strong correlation between the samples of the mineralization period (Figure 3 ). In addition, technical and biological replicates always clustered together demonstrating the robustness of the MALDI-FT-ICR-MS measurements.
These observations prompted us to examine in more detail the protein expression differences within the differentiating condition, comparing mineralization (day 19) versus the preceding premineralization period (days 5 and 10). Additionally, we included in these analyses the two extreme phenotypes, that is, day 19 in differentiating and nondifferentiating condition. In total, these comparisons led to an identification of 52 differently expressed proteins (Table 2) , according to the criteria to combine MALDI-FT-ICR-MS and LC-MS/MS data mentioned in the Materials and Methods. Among other proteins, cytoskeleton (actins, tubulins, and vimentin), actin binding (CCT2, CSRP1, FLNA, MYH9, and VCL), ECM (FN1, LGALS1), and calcium binding proteins (ANXA2, ANXA1) were identified.
Validation of Protein Expression and MS-Based
Quantification. We verified that most of the (FT-ICR-MS) quantified peptides, mapping to the same protein, have similar expression patterns ( Figure 4A ). To validate the MS data, we selected two differentially expressed proteins that have been reported to be relevant for bone biology, ANXA2 and FN1. The expression pattern of these proteins was similar for both FT-ICR-MS and Western blotting ( Figure 4A,B) . We have also performed immunocytochemistry for FN1. As expected, FN1 immunocytochemistry from mineralized day 19 osteoblasts disclosed a clear extracellular localization of this protein ( Figure  4C ).
Discussion
In vitro Human osteoblast differentiation models can be an effective model to detect proteins that have pivotal roles in bone formation and potential targets to shift bone remodeling toward the anabolic process. The introduction of mass spectrometry into the proteomics field has made this type of analysis feasible, revealing large set of proteins that can be analyzed using bioinformatics tools to discover protein associations or overrepresented biological processes.
In the present work, we aimed to identify and quantify proteins in an effort to gain knowledge about the osteoblast differentiation process and identify novel proteins that may modulate osteoblast mineralization. To this end, we exploited our very well characterized human preosteoblast cell model 5, 15 and mass spectrometric analyses to identify proteins against the background of osteoblast differentiation and in vitro bone formation. Furthermore, we aimed to assess quantitative differences both between differentiated mineralized cultures and their nondifferentiated counterparts, as well as between the premineralization and mineralization periods of the differentiated osteoblast culture. With regard to the protein profile of differentiating osteoblasts, we have identified 381 proteins. GO analysis revealed that cytoskeleton and cytoskeletal related processes were among the highest overrepresented terms. This shows the importance of specific cytoskeleton assembly for osteoblast differentiation, also verified by Higuchi and co-workers. 28 It is known that actin filaments (stress fibers) are physically linked to the ECM by integrins. [28] [29] [30] These transmembrane glycoproteins can interact with ECM proteins bridging the extracellular with the intracellular compartment. This interaction affects the organization of the cytoskeleton, 31 signal transduction, and the expression of transcription factors and osteoblast-specific genes in osteoblasts. 32, 33 Other identified processes include distinct processes such as glucose metabolism and antigen presentation. New insights linking bone remodeling to energy metabolism control are described in the review by Rosen et al. 34 The fact that these processes were overrepresented can be related to the fact that ECM synthesis, maturation, and mineralization are highly demanding processes, 35 leading to mitochondrial and antioxidant enzyme changes. 36 Interestingly, our data show a high overrepresentation of proteins belonging to the MHC class I protein complex involved in antigen presentation. Already back in 1989, Skjødt and coworkers 37 reported that osteoblast-like cells function as antigen presenting cells, being able to stimulate peripheral bone marrow cells (PBMCs). Since osteoclasts are derived from PBMCs, it is tempting to speculate that overrepresentation of this type of proteins may be related to the osteoblast effectiveness to stimulate osteoclast differentiation from their precursors or to interact with hematopoietic stem cells in the stem cell niche. 38 Phosphatases and ion channels constitute another group of proteins identified. Some of these proteins have been identified already as important players during osteoblast differentiation. This is the case for the nuclear transmembrane ion channel protein, chloride intracellular channel 1 (CLIC1). Knockdown of CLIC1 suppresses osteoblast differentiation from MSCs, whereas protein overexpression increases osteogenic markers such as ALP activity. 39 Other interesting proteins include the voltage-dependent anion channel 1, 2, and 3 (VDAC1, VDAC2, and VDAC3). These membrane proteins play a role in the efflux of metabolites including ATP and phosphate in the mitochondria. 40 Interestingly, these proteins are recurrently identified in matrix vesicles (MV), 14, 41 the organelles implicated in initiation of mineralization. 41, 43 Start of mineral deposition occurs by accommodating the proper environment for crystal growth in the MV. This implicates mobilization of calcium and phosphate to form hydroxyapatite. Phosphate mobilization can be achieved by degradation of pyrophosphate (PPi), a mineralization inhibitor, into free phosphate (Pi). Our data show that enzymes involved in this process were overrepresented by more than 2-fold (GO:0016462 pyrophosphatase activity, Figure 2A ) supporting its importance for osteoblast-mediated ECM mineralization.
In our quantitative MALDI-FT-ICR-MS approach, we identified 52 differentially expressed proteins between day 19 mineralized and day 19 nonmineralized osteoblasts and between day 19 mineralized and the osteoblast premineralization time points, day 5 and day 10. Some of these proteins will be discussed in more detail. We found that cytoskeleton components (several actins, tubulins, and vimentin) and actin binding proteins (CCT2, CSRP1, FLNA, MYH9, and VCL) were differentially expressed in differentiating osteoblasts. This follows the data discussed above and further substantiates a prominent role for cytoskeletal reorganization in osteoblast differentiation. ECM (FN1, LGALS1) and calcium binding (ANXA2, ANXA1) proteins were also identified among differentially expressed proteins. FN1 is an abundant ECM glycoprotein with significantly higher Figure 3 . Pearson correlation plot of the 422 significant differentially expressed peptide masses as determined by FT-ICR-MS measurements. All samples, from both differentiating and nondifferentiating osteoblasts, are plotted against each other to determine their degree of similarity based on the determined quantitative peptide profile. Lines and geometric shapes: black, nondifferentiating condition; yellow and orange, differentiating condition, premineralization and mineralization period, respectively. Geometric shapes: circles, day 19; squares, day 10; pentagons, day 5; filled, empty and striped shapes represent the 3 biological replicates, measured each in 3 technical replicates (with exception to a technical replicate from day 10 nondifferentiating condition that was excluded from the analysis); Red, high similarity; blue, low similarity.
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Alves et al. expression, at all time points analyzed, in differentiating osteoblasts relative to their nondifferentiated counterparts ( Figure 4A ,B). FN1 is required for osteoblast differentiation and mineralization through interaction with the integrin R5 1 FN1 receptor. 44 Besides determining osteoblast cellular fate, FN1 is also required for their survival once osteoblasts are mature. 45 We identified ANXA2 as a protein that was enhanced during stages of premineralization. Other studies showed that osteoblasts overexpressing ANXA2 show enhanced mineralization. 46 ANXA2 is a calcium-dependent phospholipid binding protein located in the ECM and in MV 14, 43 where they are thought to be important for Ca 2+ uptake. 47 The fact that we observed the highest expression of ANXA2 in the premineralization phase might be associated with increasing ALP activity verified at this stage and the start of Ca 2+ uptake into the MV. Interestingly, ANXA2 has been shown to be an autocrine factor for osteoclasts, increasing osteoclastogenesis and resorption. 48 , 49 Here we show that ANXA2 was also expressed and regulated during osteoblast differentiation making it tempting to speculate about implications in the osteoblast-osteoclast crosstalk.
LMNA belongs to the nuclear inner membrane class of proteins. Mutations in this gene display a phenotype compatible with progeria syndrome exhibiting loss of subcutaneous fat, muscular dystrophy, and an osteoporotic phenotype. 22 The bone phenotype is thought to be due to a deficit in osteoblast and matrix formation. 50, 51 Our data supports the importance of this protein for osteoblast differentiation, with higher expression in differentiating cells. However, while ANXA2 and FN1 levels were higher prior to mineralization, LMNA expression peaked when cells were mature. This difference in expression pattern is probably related to the physiological changes of the osteoblast in its progression toward osteocyte. Thus, these proteins seem to represent hallmarks of the period of osteoblast development, ANXA2 and FN1 of the premineralization, and LMNA of the mineralization period.
Also proteins were specifically suppressed in late staged differentiating osteoblasts, including PLOD2, NTE5, and LGALS1. PLOD2 forms hydroxylysine residues in -Xaa-LysGly-sequences in collagens that serve as sites of attachment for carbohydrate units being essential for the stability of the intermolecular collagen cross-links. Mutations in PLOD2 cause Bruck Syndrome in which the bone collagen lacks pyridinolines and the other cross-links based on hydroxylysine aldehydes. 52 NTE5, more often referred to as CD73, is a glycosyl phosphatidylinositol (GPI) plasma membrane anchored enzyme, 53 regarded as a MSC marker. 54, 55 LGALS1 is a -galactoside-binding protein that has been implicated in several processes from cell adhesion and migration 56 to proliferation 57 and apoptosis. 58 Human fetal MSCs upon exposure to LGALS1 enter myogenic differentiation. 59 Downregulation of PLOD2 upon mineralization is perhaps an indication that collagen cross-linking regulation is mostly needed in the premineralization stage, when ECM is actively synthesized. NTE5 and LGALS1 decreased expression might be a sign of cellular maturity toward fully differentiated osteoblasts.
Like any other approach, the use of the MALDI-FT-ICR-MS for label-free quantitation has its own advantages and disadvantages. Among the latter is the need to use an independent platform to identify the peptides/proteins profiled, due to the inability to generate good fragmentation data on single charged MALDI ions in FTMS by collisioninduced dissociation. 60 On the other hand, MALDI-FT-ICR-MS data does not require extensive data processing and analysis. Other advantages include the high sensitivity and high mass resolution described elsewhere, [60] [61] [62] and the superior reproducibility of these MS measurements, crucial in quantitative proteomics. Variation of peptide intensity measurements was as low as 15% in technical replicates and 36% considering biological replicates. For the majority of the different peptides detected that belong to the same protein, the FT-ICR-MS determined expression patterns were similar. Moreover, immunodetection of FN1 and ANXA2 confirmed their up-regulation in differentiated osteoblasts compared to their nondifferentiating counterparts.
From the list of proteins generated, it is evident that classical osteoblast markers such as RUNX2, ALPL, SPP1, BGLAP, and SPARC were not observed. We believe that this was due to the fact that their concentrations were low and beyond the range we could detect. In human cells, the range of protein copy numbers is 7-8 orders of magnitude, 63 while MS analysis can only cover up to 4-6. 64 To tackle this problem, we believe that the approach here described should be combined with the isolation of subcellular and ECM proteomes.
This study aimed to contribute to the knowledge of the osteoblast differentiation program by an unbiased mass spectrometry-based proteomics approach. Qualitative analysis revealed not only proteins expressed by differentiating osteoblasts, but also biological processes and molecular functions that drive cells toward bone formation and mineralization. At this level, cytoskeleton, energy metabolism, and antigen presentation processes were among the most overrepresented categories. Complementation of the analysis with quantitative differences revealed both bone related proteins, with characteristic expression patterns in the course of differentiation (ANXA2, FN1, and LMNA), and other proteins (e.g., LGALS1) not extensively studied in the bone field. The identification of proteins having a proven role in bone function in addition to others with yet unknown bone function strongly supports that the latter are also important for osteoblast differentiation and mineralization. Altogether, our data provides more information in the pursuit of targets for bone formation modulation, which is of utmost importance to develop new therapies for bone related diseases such as osteoporosis.
